PRNewsWire - Health

TuHURA Biosciences and Kineta Present Updated Results from Kineta's Phase I-II Study of KVA12123 and TuHURA's Mechanism of IFx-Hu2.0 Responses After Anti-PD-1 Therapy Failure in Advanced Melanoma at the American Association for Cancer Research Annual Meeting
Celltrion to present six abstracts in inflammatory bowel disease (IBD) at 2025 Digestive Disease Week® (DDW)
Precision AQ Appoints Dan Cummings as Chief Commercial Officer
24 Hour Fitness Unveils New Amenity Concepts Designed to Redefine the Member Experience